We are live on ! Find out more
ZOM

Zomedica Corp.

Delisted

ZOM was delisted on the 4th of March, 2025.

32 hedge funds and large institutions have $3.28M invested in Zomedica Corp. in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 2

44% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 9

14% more funds holding

Funds holding: 2832 (+4)

45% less capital invested

Capital invested by funds: $5.94M → $3.28M (-$2.66M)

Holders
32
Holders Change
+4
Holders Change %
+14.29%
% of All Funds
0.65%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
10
Reduced
2
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
VFA
26
Voya Financial Advisors
Connecticut
$1K
Millennium Management
27
Millennium Management
New York
$316 +$260K +1,888,860 +192%
BlackRock
28
BlackRock
New York
-$221K -930,154 Closed
Barclays
29
Barclays
United Kingdom
-$84.7K -614,320 -100%
CCFM
30
Clear Creek Financial Management
Washington
-$95K -400,000 Closed
ECM
31
ETrade Capital Management
Virginia
-$3K -14,091 Closed
HighTower Advisors
32
HighTower Advisors
Illinois
-$3K -14,000 Closed
KF
33
Krilogy Financial
Missouri
-$2K -10,000 Closed
RCA
34
Ranch Capital Advisors
Florida
-$1K -10,000 Closed
S
35
SignatureFD
Georgia
-$2K -9,000 Closed
CAPTRUST Financial Advisors
36
CAPTRUST Financial Advisors
North Carolina
-$1K -4,346 Closed
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
-$54 -225 Closed
Wells Fargo
38
Wells Fargo
California
+$477 +3,458 New

ZOM Hedge Fund Activity: Q3 2020 in Review

32 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q3 2020, worth a combined $3.28M — down 45% from $5.94M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ZOM positions and 9 closed out — a net gain of 4 holders — while 10 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $387K. The largest seller was BlackRock, exiting entirely with an estimated $221K sold.

  • 32 institutional investors held Zomedica Corp. (ZOM) as of Q3 2020, up from 28 in Q2 2020.
  • Funds reported $3.28M of Zomedica Corp. stock for Q3 2020, down 45% quarter-over-quarter.
  • 13 funds opened new Zomedica Corp. positions in Q3 2020 and 9 closed out, a net change of +4 holders.
  • The largest Zomedica Corp. buyer in Q3 2020 was Vanguard Group, an estimated $387K added.
  • The largest Zomedica Corp. seller in Q3 2020 was BlackRock, an estimated $221K sold.

Based on aggregated 13F filings for Q3 2020.